SAIPARENT vs VIVOBIOT: Stock Comparison
SAI PARENTERALS is the larger company by market capitalisation. SAI PARENTERALS shows a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SAIPARENT leads 2; VIVOBIOT leads 0 of 7
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | SAIPARENT | VIVOBIOT |
|---|---|---|
| Live Price | ₹483 | ₹13.63 |
| Day Change | -0.88% | -5.15% |
| Volume | 65,785 | 20,155 |
| 52-Week High | ₹706 | ₹20.94 |
| 52-Week Low | ₹400 | ₹12.8 |
| Distance from 52W High | -31.59% | -34.91% |
Valuation
| Metric | SAIPARENT | VIVOBIOT |
|---|---|---|
| Market Cap | ₹2,134 Cr | ₹30 Cr |
| P/E Ratio | 149.52x | — |
| P/B Ratio | 4.35x | — |
| EPS | ₹1.79 | ₹0.08 |
| Book Value | ₹112.07 | ₹41.98 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | SAIPARENT | VIVOBIOT |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | SAIPARENT | VIVOBIOT |
|---|---|---|
| ROE | 10.63% | — |
| ROCE | 20.92% | — |
| Net Margin | 3.74% | 0% |
| Operating Margin | 10.51% | — |
| Debt to Equity | 0.65x | — |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | SAIPARENT | VIVOBIOT |
|---|---|---|
| Promoter Holding | 51.16% | 30.62%▼ 4.81 pp |
| FII Holding | 2.85%▼ 1.18 pp | 0% |
| DII Holding | 7.84%▼ 0.69 pp | 0% |
| Public Holding | 38.15%▲ 1.86 pp | 69.38%▲ 4.81 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SAI PARENTERALS and VIVO BIO TECH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.